More Syntara Limited news
Syntara LimitedASX: SNT

Pharmaxis Announces First Relaunch Sales of Aridol in USA

Dec 12, 2018 at 9:49 PM EST · Issued by Syntara Limited

Filed with ASX · Dec 12, 2018 at 9:49 PM EST · 2 pages · English

On 6ix: 6ix.com/news/pharmaxis-announces-first-relaunch-sales-of-aridol-in-usa

Syntara Limited on 6ix

Story so far

  • FDA Factory Approval and Relaunch of Aridol in US MarketAug 15, 2018

Earlier from Syntara

  • Pharmaxis AGM - CEO PresentationNov 22, 2018
  • LOX Inhibitor Program for Pancreatic Cancer Phase 1 ReadyNov 19, 2018
  • Pharmaxis Releases Positive Results of Phase 1 Clinical TriaNov 14, 2018
  • Positive Phase 1 Results of Phase 1 Study - LOXL2 InhibitorOct 10, 2018
  • FDA Factory Approval and Relaunch of Aridol in US MarketAug 14, 2018

Later from Syntara

  • Pharmaxis announces resubmission of bronchitol nda in usaDec 19, 2018
  • Pharmaxis Announces LOXL2 Program Phase 2 ReadyJan 16, 2019
  • Quarterly Shareholder Update - December 2018Jan 29, 2019
  • Pharmaxis Commences Phase 1 LOX Clinical TrialFeb 21, 2019
  • Quarterly Shareholder Update - March 2019Apr 29, 2019
All Syntara news releases↗

Follow Syntara into a list and get an email when it puts out news.

Follow Syntara
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer